| Page No 1 2 3 4 5 |
| Phrase | Consultant | Town | Special Interests |
| acute oncology | *Consultant(s)* | *Towns* | Medical oncology, ovarian cancer, acute oncology |
| acute oncology | *Consultant(s)* | *Towns* | Medical oncology, acute oncology, melanoma |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast malignancies, urological malignancies |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, skin cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology, penile cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, head and neck cancer, maxillofacial cancers, radiotherapy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, urological cancer, renal cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, radiotherapy, chemotherapy, immunotherapy, metastatic cancer, lung cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology, colorectal cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, colorectal cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, neuro-oncology, stereotactic radiosurgery |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, paediatric oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, colorectal cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, genito-urinary cancers, skin cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck oncology, upper gastrointestinal malignancy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, tumours of the thorax and lower gastrointestinal tract, lung cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, gastrointestinal oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, lung cancer and mesothelioma |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck cancer, neuro-oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, genito-urinary cancers |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, neuro-oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology, radiotherapy for melanoma, medical education |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, central nervous system tumours |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, gynaecological oncology, genito-urinary oncology, radiotherapy for haematological malignancies |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, prostate cancer, bladder cancer, colorectal cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, thoracic malignancies, medical education |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology (bladder, prostate), renal and testicular cancers, low dose rate and high dose rate prostate radiotherapy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology, lung cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, prostate cancer, testicular cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, gynaecological oncology, colorectal cancer, anal cancer, medical education |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck cancers, urological malignancies |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, soft tissue and bone sarcomas, gastrointestinal stromal tumours - GIST, oropharyngeal cancer, head and neck sarcomas, prostate cancer, bladder cancer, late radiotherapy toxicity, survivorship - resilience for patients |
| Page No 1 2 3 4 5 |
